Top Institutions in Dermatopathology and Melanoma Research
Leading institutions utilize integrated diagnostic approaches combining immunohistochemistry, next-generation sequencing, DNA methylation profiling, and tumor mutation burden analysis to characterize rare cutaneous tumors and refine melanoma diagnosis, guiding targeted therapies and immunotherapy decisions.
-
#1
Memorial Sloan Kettering Cancer Center
New York, NY
MSKCC is a global leader in melanoma research and precision oncology, with extensive expertise in molecular diagnostics and immunotherapy clinical trials for rare and complex cutaneous malignancies.
Key Differentiators
- Dermatopathology
- Melanoma Research
- Molecular Oncology
-
#2
Dana-Farber Cancer Institute
Boston, MA
Dana-Farber has a robust melanoma program emphasizing translational research and molecular characterization of melanoma subtypes, including rare variants, and is a leader in immunotherapy development.
Key Differentiators
- Melanoma Research
- Molecular Pathology
- Immunotherapy
-
#3
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is recognized for its integrated dermatopathology and molecular diagnostics programs, with significant contributions to understanding melanoma biology and diagnostic challenges in rare cutaneous tumors.
Key Differentiators
- Dermatopathology
- Cutaneous Oncology
- Molecular Diagnostics
-
#4
Johns Hopkins University School of Medicine
Baltimore, MD
Johns Hopkins has a distinguished dermatopathology division with expertise in molecular tumor profiling and melanoma research, contributing to improved diagnostic accuracy and novel biomarker discovery.
Key Differentiators
- Dermatopathology
- Molecular Oncology
- Melanoma Research
-
#5
Mayo Clinic
Rochester, MN
Mayo Clinic combines comprehensive dermatopathology services with advanced molecular diagnostics and clinical expertise in melanoma, supporting accurate diagnosis and personalized treatment approaches.
Key Differentiators
- Dermatopathology
- Cutaneous Oncology
- Molecular Pathology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
